Cytokinetics Inc. (CYTK)

13.00
NASDAQ : Health Technology
Prev Close 13.17
Day Low/High 12.87 / 13.24
52 Wk Low/High 5.75 / 14.94
Avg Volume 434.40K
Exchange NASDAQ
Shares Outstanding 58.68M
Market Cap 772.80M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers

The South San Francisco, Calif.-based firm said its Phase 3 study of tirasemtiv in patients with amyotrophic lateral sclerosis did not achieve primary or secondary endpoints.

These Stocks Are Trending Up With Monster Volume

These Stocks Are Trending Up With Monster Volume

Let's take a look at several stocks that are experiencing unusual volume activity.

Stocks Up as Deals Get Done

Stocks Up as Deals Get Done

Stocks are higher on deals as Microsoft buys Nokia and Jarden buys Yankee Candle Company.

TSRX, CYTK, ARRY: 3 Stocks on TV

TSRX, CYTK, ARRY: 3 Stocks on TV

StockMarketMentor.com founder Dan Fitzpatrick details how to play three stocks Jim Cramer discussed on CNBC's "Mad Money" last night.